A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.
about
Bisphosphonate therapy in pediatric patientsZoledronate inhibits ischemia-induced neovascularization by impairing the mobilization and function of endothelial progenitor cellsMoving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology.Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology GroupSIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsIn vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.Inflammation: what role in pediatric cancer?Ten challenges in the management of neuroblastoma.Emerging drugs for neuroblastoma.Metronomics: towards personalized chemotherapy?More than the genes, the tumor microenvironment in neuroblastoma.Zoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor.Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.Advances in emerging drugs for the treatment of neuroblastoma.Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment.Zoledronate and pamidronate depress neutrophil functions and survival in mice.Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC.Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis.Bisphosphonate conjugation for bone specific drug targeting.
P2860
Q26830702-09FE0ED9-B9A2-4155-8D04-C1DDD59DF050Q34358196-C056CC52-6482-4B43-AFAA-8F92405B676DQ35116804-360DB76F-0679-4A85-A951-DFD818332DDAQ35755392-34737412-2243-4771-A87C-ACEEEA60088BQ36883879-744661D1-BC2B-49FE-921F-88AA192A8AEDQ36946864-2D3B0E95-52AE-42EC-A645-81FA05BA8B9CQ37461968-D9B00543-937A-44C5-92E0-95D67AEDC515Q37605828-35BAA03E-8C86-4493-A3F3-D4306F520AE1Q37967667-64C7C213-56A1-4F30-8B60-32474DE2CE5FQ38029366-BDD29FBA-ABC5-44A8-903D-ABBFB19828C2Q38108399-0044C2DC-A2EF-412F-9583-7125E24A1310Q38218923-1D7F1849-63D2-42E8-BFAE-30FD4246952FQ38644731-6B7686B4-D964-4A4E-8410-9E458D25546DQ38875042-8BC79B5A-37E4-44DF-9D14-ED4A6B309B42Q39157991-4762170B-AEDB-48F2-8458-152608453084Q39158415-4F62D153-D5AA-4CB9-BDBF-C72D1A0080ABQ40306627-DB5F407B-738E-4A4C-B087-6A95D3D362E7Q40726282-0208520D-76A1-42D9-9B35-1AF29FB91DD8Q46745795-AF8A6587-99C2-4714-AEA1-ECB36C3F8D29Q47104810-060A9550-C7E6-4A43-A4AE-5724AA50B4EDQ55515922-3E688B7B-3F2F-49C1-8940-B52D2075FA8F
P2860
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A phase I study of zoledronic ...... blastoma therapy (NANT) study.
@ast
A phase I study of zoledronic ...... blastoma therapy (NANT) study.
@en
type
label
A phase I study of zoledronic ...... blastoma therapy (NANT) study.
@ast
A phase I study of zoledronic ...... blastoma therapy (NANT) study.
@en
prefLabel
A phase I study of zoledronic ...... blastoma therapy (NANT) study.
@ast
A phase I study of zoledronic ...... blastoma therapy (NANT) study.
@en
P2093
P2860
P356
P1476
A phase I study of zoledronic ...... blastoma therapy (NANT) study.
@en
P2093
Andrej Skerjanec
Araz Marachelian
Heidi V Russell
Hollie A Jackson
Howard Katzenstein
Judith G Villablanca
Julie R Park
Katherine K Matthay
Randy Hawkins
Susan G Groshen
P2860
P304
P356
10.1002/PBC.22821
P577
2010-11-12T00:00:00Z